Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $250
كاردينال هيلث إنك
Cardinal Health, Inc. CAH | 0.00 |
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:
CAH) with a Outperform and raises the price target from $240 to $250.
